The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - AFR-Oncology; GenoScience Pharma
Leadership - GenoScience Pharma
Stock and Other Ownership Interests - GenoScience Pharma
Consulting or Advisory Role - Ipsen; Lilly; Novartis; Pfizer; PharmaEngine
Travel, Accommodations, Expenses - Ipsen; Lilly; Novartis; Pfizer
First-in-human phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of oral GNS561, a palmitoyl-protein thioesterase 1 (PPT1) inhibitor, in patients with primary and secondary liver malignancies.
 
James J. Harding
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; Exelixis; Imvax; Lilly; Merck; Zymeworks
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Debiopharm Group (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Polaris (Inst); Yiviva (Inst); Zymeworks (Inst)
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche
 
Thomas Decaens
No Relationships to Disclose
 
Gael Roth
No Relationships to Disclose
 
Philippe Merle
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Ipsen; Lilly; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Roche
 
Nuria Kotecki
No Relationships to Disclose
 
Chantal Dreyer
No Relationships to Disclose
 
Christelle Ansaldi
Employment - GenoScience Pharma
Stock and Other Ownership Interests - GenoScience Pharma
Consulting or Advisory Role - Gilead Sciences
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences
 
Madani Rachid
Employment - GenoScience Pharma
 
Soraya Mezouar
Employment - GenoScience Pharma
 
Agnes Menut
Employment - GenoScience Pharma
 
Eloine Bestion
Employment - GenoScience Pharma
 
Valerie Paradis
No Relationships to Disclose
 
Philippe Halfon
Employment - GenoScience Pharma
 
Eric Raymond
No Relationships to Disclose
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Agios; AstraZeneca; Autem Medical; Bayer; BeiGene; Berry Genomics; Celgene; CytomX Therapeutics (I); Eisai; Flatiron Health; Genoscience Pharma; Gilead Sciences; Gilead Sciences; Incyte; Ipsen; LAM Therapeutics; Lilly; Loxo (I); Merck Serono; Minapharma; QED Therapeutics; RedHill Biopharma; Roche/Genentech; Silenseed (I); Sillajen; SOBI (I); TheraBionic; twoXAR; Vector Health; Yiviva
Research Funding - Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Exelixis (Inst); Incyte (Inst); Polaris (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris